Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2015 Update

Date: September 16, 2015
Pages: 33
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: V7B8375C455EN
Leaflet:

Download PDF Leaflet

Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2015 Update
Summary

Vermillion, Inc. (Vermillion) is a healthcare service provider that develops and commercializes multi-marker, diagnostic tests which addresses unmet needs in gynecologic oncology and women’s health. The company’s products includes OVA1 product. Its OVA1 is a simple blood test which measures the levels of five proteins found in the blood and then uses a proprietary software called OvaCalc to calculate a single score. Vermillion’s research and development center develops and validates biomarkers and algorithms. The company collaborates with other academic institutions in oncology, cardiology and women’s health. Vermillion is headquartered in Austin, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Vermillion, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Vermillion, Inc. Company Snapshot
Vermillion, Inc. Company Overview
Key Information
Vermillion, Inc. Pipeline Products and Clinical Trials Overview
Vermillion, Inc. – Pipeline Analysis Overview
Key Facts
Vermillion, Inc. - Major Products and Services
Vermillion, Inc. Pipeline Products by Development Stage
Vermillion, Inc. Pipeline Products Overview
Biomarker Assay - Breast Cancer
Biomarker Assay - Breast Cancer Product Overview
Biomarker Test - Prostate Cancer
Biomarker Test - Prostate Cancer Product Overview
Diagnostic Assay - Alzheimer's Disease
Diagnostic Assay - Alzheimer's Disease Product Overview
Diagnostic Assay - Colorectal Cancer
Diagnostic Assay - Colorectal Cancer Product Overview
MammoCheck
MammoCheck Product Overview
OVA2
OVA2 Product Overview
OvaCheck
OvaCheck 2 Product Overview
ProstaCheck
ProstaCheck Product Overview
VASCLIR
VASCLIR Product Overview
Vermillion, Inc. - Key Competitors
Vermillion, Inc. - Key Employees
Vermillion, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Vermillion, Inc., Recent Developments
Sep 01, 2015: Vermillion Announces Launch of New Website in Conjunction with Ovarian Cancer Awareness Month
Aug 19, 2015: Vermillion Announces Key Medical Policy Coverage for OVA1 Test
Aug 13, 2015: Vermillion Reports Second Quarter 2015 Financial Results and Business Update
Jul 13, 2015: ASPiRA Labs Receives New York State Permit
May 14, 2015: Positive Top-Line Results Regarding OVA2 Development and Clinical Validation to be Presented at American Society for Clinical Oncology Conference
May 11, 2015: Vermillion Reports First Quarter 2015 Financial Results and Provides Business Update
Apr 27, 2015: Vermillion Announces Expanded Medical Policy Coverage for OVA1 Test
Apr 02, 2015: Vermillion Names Fred Ferrara to Newly Created CIO Post
Mar 25, 2015: Vermillion Reports Fourth Quarter and Full Year 2014 Results
Mar 17, 2015: Vermillion and Quest Diagnostics Announce New Commercial Agreement
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Vermillion, Inc., Key Facts
Vermillion, Inc. Pipeline Products and Clinical Trials Overview
Vermillion, Inc. Pipeline Products by Equipment Type
Vermillion, Inc. Pipeline Products by Indication
Vermillion, Inc., Key Facts
Vermillion, Inc., Major Products and Services
Vermillion, Inc. Number of Pipeline Products by Development Stage
Vermillion, Inc. Pipeline Products Summary by Development Stage
Biomarker Assay - Breast Cancer - Product Status
Biomarker Assay - Breast Cancer - Product Description
Biomarker Test - Prostate Cancer - Product Status
Biomarker Test - Prostate Cancer - Product Description
Diagnostic Assay - Alzheimer's Disease - Product Status
Diagnostic Assay - Alzheimer's Disease - Product Description
Diagnostic Assay - Colorectal Cancer - Product Status
Diagnostic Assay - Colorectal Cancer - Product Description
MammoCheck - Product Status
MammoCheck - Product Description
OVA2 - Product Status
OVA2 - Product Description
OvaCheck 2 - Product Status
OvaCheck 2 - Product Description
ProstaCheck - Product Status
ProstaCheck - Product Description
VASCLIR - Product Status
VASCLIR - Product Description
Vermillion, Inc., Key Employees
Vermillion, Inc., Subsidiaries

LIST OF FIGURES

Vermillion, Inc. Pipeline Products by Equipment Type
Vermillion, Inc. Pipeline Products by Development Stage
Skip to top


Ask Your Question

Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: